Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Cell Technology (ACT) is a biotechnology company specializing in the collection, processing, and long-term storage of autologous adult stem cells and fibroblasts. The company operates a cGMP-compliant laboratory where it expands a patient's own cells for future therapeutic use in regenerative medicine and aesthetic applications. ACT provides a platform for physicians to offer personalized cell-based treatments by ensuring the availability of high-quality, potent cellular material. Their services focus on preserving cellular health today for potential medical needs tomorrow, bridging the gap between current cell banking and future clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Cell Technology.